Editorial p1 Cancer consequences of the HIV funding crisis The Lancet Oncology +++ +...

Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial Anne Sophie V M van den Heerik, MDa a.v.m.van_den_heerik@lumc.nl ∙ Nanda Horeweg, MD PhDa ∙ Marie A D Haverkort, MDb ∙ Nienke Kuijsters, MD PhDc ∙ Prof Stefan Kommoss, MDd ∙ Friederike L A Koppe, MDe ∙ et al. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00612-6/abstract?utm_campaign=update-lanonc&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanonc&_hsenc=p2ANqtz-_AaY3oopcXHJyj-RsT_unJdWZ23e6O7tuLccqiix9JTXvhUp7Q7X_MgYc-VD3teuHMJqjlj4UHbBpPM7iJMauIyyCHfg&_hsmi=398065637&utm_content=397506411&utm_source=hs_email A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 1: intraoperative recommendations for mapping, monitoring, and decision making Jasper K W Gerritsen, MD PhDa,b,* j.gerritsen@erasmusmc.nl ∙ Philipp Karschnia, MD MScc,d,* ∙ Prof Lorenzo Bello, MD PhDe,f ∙ Prof Shawn Hervey-Jumper, MDb ∙ Jacob S Young, MDb ∙ Prof Kathleen Seidel, MDg ∙ et al. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00531-5/abstract?utm_campaign=update-lanonc&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanonc&_hsenc=p2ANqtz-8C94kfpm-XV13X-MPna32mLSPatOQ4szEyiblseLoVvaWcXriEWGOvGjA7CLVdr9y1liqhlG6JB0nE3-DIvuDytfvTCg&_hsmi=398065637&utm_content=397506411&utm_source=hs_email Current landscape, successes, and key challenges in cancer vaccine clinical trials across the UK Robert A Watsona,b robert.watson@oncology.ox.ac.uk ∙ Darcy Wardc ∙ Pippa Corried ∙ Elisa Fontanae ∙ William Inced ∙ Victoria Kunenef ∙ et al. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00723-5/abstract?utm_campaign=update-lanonc&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanonc&_hsenc=p2ANqtz--sliKeyJktFRiq_3dmyg4zmjgma8wCzsgZtQ7ORgAn1T8exWS5tSkHfG6VoQ2dhLs-JGpj77kLAPsHnr3Kvi2wxopkFQ&_hsmi=398065637&utm_content=397506411&utm_source=hs_email Editorial p1 Cancer consequences of the HIV funding crisis The Lancet Oncology https://www.thelancet.com/journals/lanonc/issue/vol27no1/PIIS1470-2045(25)X0013-9